INTERVIEW: New era for Eucomed sharing knowledge the new mantra
This article was originally published in Clinica
The European medtech industry association, Eucomed, represents a hugely diverse range of medical device manufacturers constantly facing new challenges as technologies evolve, together with the sophistication of regulating them. Have matters reached a point where a radical rethink is required? That was the question Amanda Maxwell put to chairman Guy Lebeau
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.